In this episode of the ChinaPower podcast, Brian Hart interviews Dr. Yanzhong Huang about China's growing influence in the global pharmaceutical industry and its geopolitical implications. Dr. Huang explains the complexities of the global drug supply chain, from raw materials to finished products, highlighting China's dominance in key areas like generic APIs and precursor chemicals, as well as its rapid advancement in biotech innovation. The discussion covers how China strategically targeted the pharmaceutical industry through cost advantages, government support, and talent recruitment. Dr. Huang also addresses the United States' reliance on China for various drugs and precursors, the potential risks this poses to U.S. national security, and possible strategies for mitigating these risks, including targeted reshoring and diversification of supply chains.
Sign in to continue reading, translating and more.
Continue